{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:33:55Z","timestamp":1787697235543,"version":"build-2784847793"},"reference-count":15,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5,1]]},"DOI":"10.1210\/jc.2008-0019","type":"journal-article","created":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T01:34:24Z","timestamp":1204076064000},"page":"1860-1864","source":"Crossref","is-referenced-by-count":17,"title":["Gluteal Nodules in Patients with Metastatic Midgut Carcinoid Disease Treated with Depot Somatostatin Analogs"],"prefix":"10.1210","volume":"93","author":[{"given":"Miguel","family":"Debono","sequence":"first","affiliation":[{"name":"Unit of Endocrinology and Department of Radiology, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lye-Quen","family":"Hon","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology and Department of Radiology, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Bax","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology and Department of Radiology, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Blakeborough","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology and Department of Radiology, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Newell-Price","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology and Department of Radiology, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041116133534500_R1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","article-title":"The diagnosis and medical management of advanced neuroendocrine tumors.","volume":"25","author":"Kaltsas","year":"2004","journal-title":"Endocr Rev"},{"key":"2019041116133534500_R2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1023\/A:1012272314550","article-title":"Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.","volume":"12","author":"Quaedvlieg","year":"2001","journal-title":"Ann Oncol"},{"key":"2019041116133534500_R3","first-page":"822","article-title":"Prognosis and survival in patients with gastrointestinal tract carcinoid tumors","author":"Shebani","year":"1999","journal-title":"Ann Surg 229:815\u2013821; discussion"},{"key":"2019041116133534500_R4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008215730767","article-title":"Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.","volume":"8","author":"Janson","year":"1997","journal-title":"Ann Oncol"},{"key":"2019041116133534500_R5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.1999.17.2.600","article-title":"Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.","volume":"17","author":"Rubin","year":"1999","journal-title":"J Clin Oncol"},{"key":"2019041116133534500_R6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2036.2003.01420.x","article-title":"Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experience.","volume":"17","author":"Garland","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"2019041116133534500_R7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000082875","article-title":"Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.","volume":"80","author":"Ruszniewski","year":"2004","journal-title":"Neuroendocrinology"},{"key":"2019041116133534500_R8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1023\/A:1008383132024","article-title":"Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.","volume":"11","author":"Ricci","year":"2000","journal-title":"Ann Oncol"},{"key":"2019041116133534500_R9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.38.3.430","article-title":"Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.","volume":"38","author":"Arnold","year":"1996","journal-title":"Gut"},{"issue":"Suppl 4","key":"2019041116133534500_R10","first-page":"iv1","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours","volume":"54","author":"Ramage","year":"2005","journal-title":"Gut"},{"key":"2019041116133534500_R11","first-page":"207","article-title":"Pathogenesis and treatment of pain caused by skin metastases in neuroendocrine tumours.","volume":"60","author":"Zuetenhorst","year":"2002","journal-title":"Neth J Med"},{"key":"2019041116133534500_R12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system.","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"key":"2019041116133534500_R13","first-page":"42","article-title":"Hepatic resection for metastatic neuroendocrine carcinomas","author":"Que","year":"1995","journal-title":"Am J Surg 169:36\u201342; discussion"},{"key":"2019041116133534500_R14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.2006.02450.x","article-title":"Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly.","volume":"64","author":"Caron","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041116133534500_R15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00003072-200107000-00025","article-title":"Buttock granulomas: a consequence of intramuscular injection of Sandostatin detected by In-111 octreoscan","volume":"26","author":"Rideout","year":"2001","journal-title":"Clin Nucl Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/5\/1860\/9058854\/jcem1860.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T05:44:45Z","timestamp":1555047885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/5\/1860\/2598914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-0019","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}